Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    17875806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: autologous PBSC transplant
2 Suspended Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Single ASCT with Thalidomide maintenance

Study has passed its completion date and status has not been verified in more than two years.